Chiropractic Therapy Offers Long Term Benefits for Fibromyalgia Sufferers

If you suffer with fibromyalgia, you are not alone, as Dr. Cohen sees many people with this particular issue in our Holtsville chiropractic office. Actually, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the USA have fibromyalgia issues. Fortunately, chiropractic treatment is one treatment option that can provide positive results.

Research Proves Chiropractic Adjustments Helps Fibromyalgia Discomfort

In a study released in mid-2015, 215 adults with fibromyalgia were assessed based on factors ranging from pain to quality of sleep to the levels of depression and anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal treatment program for three months and the second group receiving the same program plus chiropractic adjustments (specifically, to the upper neck area) for the same length of time.

The subjects who received chiropractic adjustments in addition to the multi-disciplinary treatment program reported greater benefits in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study participants who received multi-modal therapy without chiropractic adjustments. In addition, those positive benefits were long-lasting as the individuals reported continued improvement one full year later.

Fibromyalgia issues can substantially diminish your quality of life, both psychologically and physically. If you're dealing with fibromyalgia, we might be able to help.

You don't have to suffer! To see what Dr. Cohen can do for your fibromyalgia discomfort, call our Holtsville chiropractic office today.

References

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.